AKEBIA THERAPEUTICS INC (AKBA) Institutional Ownership Changes & 13F Activity
AKEBIA THERAPEUTICS INC (AKBA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Aqr Capital Management Llc, Jacobs Levy Equity Management, Inc, Bank Of America Corp, Two Sigma Investments, Lp, and Millennium Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +2,919 | +4.2% | 71,892 | $81.96K | Q2 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Buy | +465 | — | 465 | $524.00 | Q2 2026 | Sep 04, 2026 |
| Citadel Advisors Llc | Buy | +327,592 | +23.6% | 1,717,659 | $1.96M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -10,157 | -74.1% | 3,547 | $4.04K | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Buy | +100,064 | +855.8% | 111,756 | $127.40K | Q2 2026 | Aug 19, 2026 |
| Public Employees Retirement System Of Ohio | Buy | +294,900 | — | 294,900 | $336.19K | Q2 2026 | Aug 17, 2026 |
| Proficio Capital Partners Llc | Buy | +12,725 | — | 12,725 | $14.51K | Q2 2026 | Aug 17, 2026 |
| Aqr Capital Management Llc | Buy | +7,358,904 | +410.5% | 9,151,524 | $10.43M | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Buy | +3,843,357 | +894.5% | 4,273,026 | $4.87M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -2,304,612 | -83.4% | 458,750 | $522.98K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +1,138,872 | +87.8% | 2,436,673 | $2.78M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +811,892 | +34.0% | 3,196,605 | $3.64M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +694,928 | — | 694,928 | $792.22K | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +626,160 | — | 626,160 | $713.82K | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Sell | -615,508 | -25.7% | 1,779,707 | $2.03M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Sell | -536,790 | -75.8% | 170,955 | $194.89K | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +427,095 | — | 427,095 | $486.89K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -363,401 | -85.9% | 59,427 | $67.75K | Q2 2026 | Aug 14, 2026 |
| Mangrove Partners Im, Llc | Buy | +291,000 | +77.4% | 666,954 | $760.33K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +284,861 | +14.1% | 2,300,438 | $2.62M | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +138,423 | +140.5% | 236,916 | $270.08K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -132,298 | -18.3% | 589,821 | $672.40K | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Sell | -124,415 | -84.0% | 23,677 | $26.87K | Q2 2026 | Aug 14, 2026 |
| Alliancebernstein L.P. | Buy | +115,980 | +48.5% | 354,910 | $493.32K | Q2 2026 | Aug 14, 2026 |
| Cerity Partners Llc | Buy | +112,117 | — | 112,117 | $127.82K | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Sell | -102,458 | -39.7% | 155,396 | $177.15K | Q2 2026 | Aug 14, 2026 |
| Jain Global Llc | Buy | +91,416 | — | 91,416 | $104.21K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +86,340 | +2.4% | 3,689,167 | $4.21M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +71,616 | +444.7% | 87,722 | $100.00K | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Buy | +60,608 | +65.7% | 152,878 | $174.28K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about AKBA activity
Which institutional owners are buying AKBA?
Institutional owners buying AKBA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in AKBA activity?
"Buy" means an investor increased their reported position in AKBA compared to the prior reporting period. This reflects growing exposure to AKEBIA THERAPEUTICS INC (AKBA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in AKBA increasing?
Institutional interest in AKBA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related AKBA Institutional Insights
- AKBA Overview
- AKBA 13F Institutional Holders
- AKBA Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AKBA Insider Trading & SEC Form 4 Activity
- AKBA Articles
- Top Institutional Investor Stock Rankings